BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 69 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $151,000 | -61.0% | 2,064 | -70.9% | 0.04% | -44.7% |
| Q4 2019 | $387,000 | +219.8% | 7,104 | +145.0% | 0.08% | +145.2% |
| Q3 2019 | $121,000 | -9.7% | 2,900 | +11.5% | 0.03% | +72.2% |
| Q1 2019 | $134,000 | +538.1% | 2,600 | +333.3% | 0.02% | +157.1% |
| Q4 2018 | $21,000 | -78.6% | 600 | -76.9% | 0.01% | -61.1% |
| Q3 2018 | $98,000 | +63.3% | 2,600 | +8.3% | 0.02% | +100.0% |
| Q2 2017 | $60,000 | – | 2,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
| Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
| Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |